2000
DOI: 10.1177/000348940010901106
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Adenovirus Type 1 and Influenza a Virus onStreptococcus PneumoniaeNasopharyngeal Colonization and Otitis Media in the Chinchilla

Abstract: Considerable evidence has implicated respiratory tract virus potentiation of bacterial adherence, colonization, and superinfection as a significant factor contributing to the pathogenesis of otitis media (OM). Influenza A and B viruses, adenovirus, and respiratory syncytial virus are the primary respiratory tract viruses associated with this disease. Investigations have established a dramatic increase in the development of experimental OM in chinchillas co-inoculated with influenza A virus and Streptococcus pn… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

3
43
1
1

Year Published

2003
2003
2022
2022

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 43 publications
(48 citation statements)
references
References 26 publications
(26 reference statements)
3
43
1
1
Order By: Relevance
“…Influenza virus A/Alaskan (6/77) (H 3 N 2 ) was propagated and its titers were determined by a plaque assay as was previously described in detail and previously used by our laboratory (9,31,39,41). Our primary cultures of HMEE cells were infected with influenza A virus at the multiplicities of infection (MOIs) of 0.01 and 0.1 in serum-free alpha minimal essential medium (MEM␣) (Gibco BRL, Gaithersburg, Md.)…”
Section: Virusmentioning
confidence: 99%
See 1 more Smart Citation
“…Influenza virus A/Alaskan (6/77) (H 3 N 2 ) was propagated and its titers were determined by a plaque assay as was previously described in detail and previously used by our laboratory (9,31,39,41). Our primary cultures of HMEE cells were infected with influenza A virus at the multiplicities of infection (MOIs) of 0.01 and 0.1 in serum-free alpha minimal essential medium (MEM␣) (Gibco BRL, Gaithersburg, Md.)…”
Section: Virusmentioning
confidence: 99%
“…S. pneumoniae type 6A (EF 3114), kindly provided by B. Andersson, Department of Clinical Immunology, University of Gröteborg, Gröteborg, Sweden, has been described in detail previously (3). This strain has been used in previous reports from our laboratory (39,40). The isogenic opaque and transparent variants of S. pneumoniae type 6A were also used in a previous report from our laboratory (41) and originally isolated by Jeffery Weiser, Children's Hospital of Philadelphia.…”
Section: Virusmentioning
confidence: 99%
“…Neuraminidase was purified from whole-cell lysates as previously described by Lock et al (12). S. pneumoniae 6A (EF3114) was used for purification of native neuraminidase as well as intranasal inoculation in the chinchilla model of OM and has been described in detail previously (1,22). Fractions from a DEAESepharose column containing neuraminidase (identified by use of a neuraminidase assay described below) were pooled, washed, and concentrated at 4°C with buffer D (50 mM Tris base, 0.15 M NaCl, 0.1 mM Na-EDTA, 200 mM phenylmethylsulfonyl fluoride, 0.01% sodium azide) by using an Amicon stirred ultrafiltration cell model 8200 fitted with a polyethersulfone membrane with a 50,000 molecular weight cutoff (Millipore Corporation, Bedford, Mass.).…”
mentioning
confidence: 99%
“…Influenza virus A/Alaska/6/77 (H3N2) has previously been used in combination with S. pneumoniae by our laboratory and others to induce experimental OM in the chinchilla model (8,25), and it has been described in detail previously (6,16). Fourteen days following the final immunization with neuraminidase, the chinchillas were anesthetized and inoculated intranasally with approximately 6 ϫ 10 6 PFU of influenza A virus per our standard protocol (22).…”
mentioning
confidence: 99%
See 1 more Smart Citation